Factors associated with treatment failure for chemotherapy-induced nausea and vomiting (CINV) among breast cancer patients receiving adjuvant chemotherapy

被引:0
|
作者
Yeo, Winnie
Ngai, Nicole
Yeo, Horatio
Lai, Dong
Pang, Elizabeth
Kwok, Carol
Lau, Thomas
Mo, Frankie
机构
关键词
D O I
10.1158/1538-7445.SABCS23-PO1-11-12
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO1-11-12
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Acute chemotherapy-induced nausea and vomiting (CINV): a national survey
    Sichetti, Daniela
    Scurti, Veronica
    Sasso, Elisa
    Romero, Marilena
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 496 - 496
  • [32] Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy
    Mari Yokoi
    Daiki Tsuji
    Kenichi Suzuki
    Yohei Kawasaki
    Masahiko Nakao
    Hideaki Ayuhara
    Yuuki Kogure
    Kazuhiko Shibata
    Toshinobu Hayashi
    Keita Hirai
    Kazuyuki Inoue
    Toshihiro Hama
    Koji Takeda
    Makoto Nishio
    Kunihiko Itoh
    Supportive Care in Cancer, 2018, 26 : 1505 - 1513
  • [33] Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy
    Yokoi, Mari
    Tsuji, Daiki
    Suzuki, Kenichi
    Kawasaki, Yohei
    Nakao, Masahiko
    Ayuhara, Hideaki
    Kogure, Yuuki
    Shibata, Kazuhiko
    Hayashi, Toshinobu
    Hirai, Keita
    Inoue, Kazuyuki
    Hama, Toshihiro
    Takeda, Koji
    Nishio, Makoto
    Itoh, Kunihiko
    SUPPORTIVE CARE IN CANCER, 2018, 26 (05) : 1505 - 1513
  • [34] Palonosetron versus ondansetron in CINV (chemotherapy-induced nausea and vomiting)
    Vieira, S.
    Monroe, D.
    Sorita, R.
    Palomar, M.
    Librojo, M.
    Porin, L.
    Ng, J.
    Taylor, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S370 - S370
  • [35] Aprepitant for preventing chemotherapy-induced nausea and vomiting (CINV) in children
    Kang, Hyoung Jin
    Loftus, Susan
    Taylor, Arlene
    DiCristina, Cara
    Zwaan, Christian M.
    Green, Stuart
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy
    Takako Inoue
    Madoka Kimura
    Junji Uchida
    Kazumi Nishino
    Toru Kumagai
    Junko Taniguchi
    Fumio Imamura
    International Journal of Clinical Oncology, 2017, 22 : 600 - 604
  • [37] Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy
    Inoue, Takako
    Kimura, Madoka
    Uchida, Junji
    Nishino, Kazumi
    Kumagai, Toru
    Taniguchi, Junko
    Imamura, Fumio
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (03) : 600 - 604
  • [38] Management of Chemotherapy-induced Nausea and Vomiting (CINV) and Their Impact on Patients' Daily Lives
    Savary, P.
    Rigal, O.
    Varin, R.
    Daouphars, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S236 - S236
  • [39] MANAGEMENT OF ANTIEMETIC TREATMENT FOR CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV): PATIENTS', ONCOLOGISTS' AND NURSES' PERSPECTIVES
    Duracinsky, M.
    Chassany, O.
    Griffith, J.
    Coblentz-Baumann, L.
    VALUE IN HEALTH, 2018, 21 : S64 - S65
  • [40] Safety of transdermal scopolamine in pediatric patients for chemotherapy-induced nausea and vomiting (CINV)
    Weber, L. M.
    Alexander, D.
    Finkelstein, M.
    Chen, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)